|
TFDP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.21519999910447E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.09779995994109E-09 |
| Normal-vs-Stage2 |
4.232000E-04 |
| Normal-vs-Stage3 |
1.603570E-02 |
| Normal-vs-Stage4 |
9.022100E-02 |
| Stage1-vs-Stage2 |
6.335800E-01 |
| Stage1-vs-Stage3 |
1.252240E-01 |
| Stage1-vs-Stage4 |
9.751400E-01 |
| Stage2-vs-Stage3 |
4.947200E-01 |
| Stage2-vs-Stage4 |
8.592000E-01 |
| Stage3-vs-Stage4 |
5.068600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.41519999742013E-08 |
| Normal-vs-AfricanAmerican |
1.28809999999646E-06 |
| Normal-vs-Asian |
5.928600E-01 |
| Caucasian-vs-AfricanAmerican |
8.341000E-01 |
| Caucasian-vs-Asian |
6.643000E-01 |
| AfricanAmerican-vs-Asian |
6.385800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.83509984985619E-10 |
| Normal-vs-Female |
5.143400E-01 |
| Male-vs-Female |
3.15950000051579E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.431600E-04 |
| Normal-vs-Extreme_Weight |
3.74659969715196E-10 |
| Normal-vs-Obese |
1.562520E-04 |
| Normal-vs-Extreme_Obese |
3.072400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.969600E-02 |
| Normal_Weight-vs-Obese |
8.467400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.543600E-01 |
| Extreme_Weight-vs-Obese |
2.752000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.462000E-01 |
| Obese-vs-Extreme_Obese |
7.538400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.388210E-01 |
| Normal-vs-Age(41-60Yrs) |
2.16539999999821E-05 |
| Normal-vs-Age(61-80Yrs) |
9.88259996059782E-09 |
| Normal-vs-Age(81-100Yrs) |
2.18229999999764E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.780000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.727600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.542000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.609000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.734000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.225600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.4258998949972E-10 |
| Normal-VS-Type2 PRCC |
3.118100E-03 |
| Normal-VS-KIRP CIMP |
7.488800E-01 |
| Normal-VS-Unclassified PRCC |
4.199700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.076800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.421150E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.352030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.632600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.112600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.611800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.14959999484444E-09 |
| Normal-vs-N1 |
2.338800E-01 |
| Normal-vs-N2 |
8.595000E-01 |
| N0-vs-N1 |
2.535800E-02 |
| N0-vs-N2 |
5.596200E-01 |
| N1-vs-N2 |
8.857600E-01 |
|
|
